A literature search was conducted utilising the electronic databases CINAHL, PubMed and MEDLINE in August 2014 using the keywords venous thromboembolism, thromboprophylaxis, neurosurgical, head trauma, enoxaparin and intracranial bleeding. Articles were limited to English papers, which were published from 2008 to present. The reference lists of articles were searched for additional publications. A total of 30 papers were reviewed and 15 included in the review combining both contemporary literature and seminal work pieces.
Introduction
Venous Thromboembolism (VTE) encompasses both Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) (Welch, 2010) . Accounting for the death of 5-10% of hospital inpatients, PE is the most common avertible cause of inpatient death (Cohen, Tapson, Bergmann, Goldhaber, Kakkar, Deslandes, Huang, Zayaruzny, Emery & Anderson, 2008 ).
Virchow's triad as explained in Delaune, Nanda & Barker (2008) defines the three contributing factors associated with VTE formation. These factors are venous stasis which is reduced or stagnant blood flow in deep veins, venous injury which causes the release of procoagulant factors within the bloodstream as part of the normal clotting mechanism and hypercoagulability which refers to a more intrinsically active clotting state, often as a result of traumatic injury (Maclean, 2014) .
The quoted incidence of DVT in the neurosurgical setting varies from 9-50% (Delaune et al., 2008) , with patients suffering from multisystem traumatic injuries in addition to their neurotrauma, being at the greatest risk (Reiff, Haricharan, Bullington, Griffin, McGwin & Rue, 2009) . Despite the high prevalence and associated morbidity of VTE development, thromboprophylaxis in the neurosurgical setting remains a source of contention due to concerns of iatrogenic haemorrhage progression associated with anticoagulant thromboprophylaxis. There is further reticence to use early chemical VTE prophylaxis due to the absence of a national care standard and the nature of previous studies which are by majority, limited to retrospective and observational studies (Phelan, 2012) .
Review of the literature VTE is a common complication for hospitalised patients irrespective of their pathology, and no group of patients has a higher risk than those who have suffered traumatic injury (Urden, Stacy & Lough, 2015) . Taniguchi, Fukuda, Daitoku, Minakawa, Odagiri, Suzuki, Fukui, Asano & Ohkuma (2009) , conducted a prospective study of 37 patients stratified into risk categories which analysed the prevalence of venous thromboembolism in the neurosurgical setting. Their study group received thromboprophylaxis with graded compression stockings, with or without the use of intermittent pneumatic compression (IPC), but did not receive chemical prophylaxis. Their results suggested that mechanical prophylaxis alone was inadequate with the prevalence of DVT within their cohort at 13.5% which is within the expected baseline of risk in the untreated. Also of note, within their study group, of those found to have DVTs, there was a 60% prevalence of PEs requiring long term treatment. Similarly, Phelan (2012) , conducted a critical literature review of 56 papers to determine the safety and efficacy of chemical VTE prophylaxis in the setting of neurosurgical patients. They reported rates of DVTs in patients who had suffered traumatic brain injury (TBI) in the intensive care unit (ICU) setting as being as high as 51%, with a subsequent post thrombotic-syndrome rate of 30%; a syndrome, it should be noted, associated with a poorer expected long term outcome than chronic fibrotic lung disease and diabetes. They advised that initiation of low molecular weight heparin (LMWH) prophylaxis was critical once haemorrhage progression was deemed stable, suggesting 48 hours postop to be the optimal time, due to the increasing requirement of invasive prophylaxis via use of devices such as inferior vena cava (IVC) filters beyond this period. Scudday, Brasel, Webb, Codner, Somberg, Weigelt, Herrmann & Peppard (2011) , also hypothesised that the use of anticoagulant prophylaxis would decrease the incidence of VTE without increasing intracranial haemorrhage in their retrospective case control study of 812 patients. Anticoagulant prophylaxis in the form of unfractionated heparin (UFH) or LMWH was initiated in 402 (49.5%) patients. 169 commenced anticoagulant prophylaxis within 48 hours of presentation, whilst 242 patients had treatment initiated within 72 hours. Findings of the study indicated that patients receiving anticoagulant prophylaxis in contrast to mechanical prophylaxis had a reduced VTE incidence of 1% and 3% respectively.
Opinions of ideal time to initiate chemical prophylaxis for VTE within the neurosurgical community vary between clinicians. It is nevertheless rarely disputed that timely and appropriate prophylaxis of VTE reduces morbidity. A study of Canadian practice conducted by Scales, Riva-Cambrin, Le, Pinto, Cook & Granton (2009), surveyed 160 neurosurgeons and intensivists, confirming that the majority of clinicians utilised anticoagulant prophylaxis in the neurosurgical setting despite the perceived risks of haemorrhagic progression. 88% of surveyed intensivists and 75% of surveyed neurosurgeons described the use of UFH, LMWH or other anticoagulant thromboprophylaxis for patients with diffuse axonal injury after severe traumatic brain injury. The majority (58%) who favoured anticoagulant thromboprophylaxis reported that they would initiate anticoagulant thromboprophylaxis within two days of injury. In the instance of patients suffering intracranial haemorrhage after severe traumatic brain injury, 60% of those surveyed reported that they would initiate anticoagulant thromboprophylaxis during the inpatient course. In this case however, the initiation time was more varied with 34% of those surveyed stating that they would commence anticoagulant prophylaxis within two days of surgery, 57% would commence within four days and 80% within one week. The use of anticoagulant thromboprophylaxis in patients who are considered high risk for the development of VTE undergoing intracranial neurosurgery is also supported by Barillari & Pasca (2009) who state that the use of IPC in addition to low dose UFH or LMWH postoperatively is more efficient than the use of IPC alone. This statement is based on their review of guidelines presented from the American College of Chest Physicians (2008), consensus conference on antithrombotic therapy. In spite of the observed efficacy of anticoagulant thromboprophylaxis, a clinical decision analysis study conducted by Scales, RivaCambrin, Wells, Athaide, Granton & Detsky (2010) , revealed that the probability of no intracranial haemorrhage progression in the context of mechanical or anticoagulant thromboprophylaxis was associated with expected values of 0.90 (90%) and 0.89 (89%) respectively, meaning that the decision to anticoagulate patients was approximately equivocal in terms of its absolute risk. It went on however to conclude that given the implications of intracranial haemorrhage when measured against the implications of VTE, that the risks while equivalent numerically, were not necessarily contextually equal.
In favour of early anticoagulation, it has been shown that delayed time to treatment with appropriate anticoagulation therapy has been shown to have a significantly increased burden of disease. Reiff et al (2009) conducted a retrospective, multicentre study which included 15,269 eligible patients of which 2000 had sustained traumatic brain injury (TBI) investigating DVT risk dependent on admission time to commencement of prophylaxis. They found that patients suffering from TBI are associated with a high risk of DVT which became significantly greater when the presentation time to anticoagulant prophylaxis was longer. In their observed cohort when the time to commence prophylaxis was beyond 48 hours, DVT risk in TBI surged to 15.4%, compared with a significantly less risk of 3.6% in TBI patients who had prophylaxis initiated at 0-24 hours. In contradiction to their findings, the retrospective study by Salottolo, Offner, Levy, Mains, Slone & Bar-Or (2010), was not able to establish an association between the development of VTE and the timing of anticoagulant prophylaxis commencement.
Reticence to initiate anticoagulation is based on the perceived risk of haemorrhagic progression. However, some evidence suggests that intracranial haemorrhage rates within those treated with anticoagulant prophylaxis are significantly less than is intuitively assumed. In a retrospective study undertaken at an academic tertiary care facility including 4293 patients undergoing surgery for intracranial brain tumour, Chaichana, Pendleton, Jackson, Martinez-Gutierrez, Diaz-Stransky, Aguayo, Olivi, Weingart, Gallia, Lim, Brem & Quinones-Hinojosa (2013), reviewed 126 patients who acquired DVT and/or PE; 67% suffered solely DVT, 25% PE and 8% both. All were diagnosed within 30 days of surgery through a variety of means including ultrasound, CT pulmonary angiogram and ventilation perfusion scan. The majority of patients diagnosed with VTE (81 patients, 64%) were treated with UFH, and in follow up imaging only 5 (4%) had an intracranial haemorrhage. While the cohort studied was not focused purely on patients suffering TBI, given the degree of parenchymal injury associated with tumour and other surgery, a degree of extrapolation is not unreasonable. Similarly, Dudley, Aziz, Bonnici, Saluja, Lamourex, Kalmovitch, Gurasahaney, Razez, Maleki & Marcoux (2010), undertook a retrospective study that reviewed 694 cases of moderate to severe traumatic brain injury over a period of 5 years and analysed the use of LMWH for VTE prophylaxis. Eligible patients, 287 in total, were fitted with mechanical prophylaxis; both graded compression stockings and IPC, and were also commenced on LMWH at 48-72 hours post traumatic injury. It is important to note that in this instance, patients were commenced on LMWH only when two or more CT scans displayed intracranial haemorrhage. 186 patients underwent a CT scan within three weeks of commencing LMWH and only one (0.4%) developed progression of a known intracranial haemorrhage. The authors concluded that early LMWH commencement post traumatic brain injury showed a decreased incidence of VTE (7.3%) and should be considered safe given that only 0.4% suffered a progression of intracranial haemorrhage. Farooqui, Hiser, Barnes & Litofsky (2013) , concluded that the use of anticoagulant prophylaxis in head injured patients appears to be effective in preventing DVT and PE without increase in haemorrhage rates in their retrospective study of 236 patients. They reviewed an anticoagulant VTE prophylaxis protocol after TBI mandating the use of anticoagulant prophylaxis (UFH or LMWH) at 24 hours post injury for all patients. The analysis compared two groups of patients; one cohort of 107 patients treated without this protocol and the other cohort of 129 patients were in the described manner. The incidence of PE in the former was 3.74%, and 0.78% in the latter. Curiously, without the protocol, the observed number of haemorrhagic progressions, (3 incidences) was higher than those treated with the protocol (1 incident). Similarly, Minshall, Eriksson, Leon, Doben, McKinzie & Fakhry (2011) , retrospectively reviewed the charts of 386 patients admitted to an ICU with a hospital stay of greater than 48 hours with significant TBI over a 42 month period. Their aim was to compare the use of LMWH and UFH to better gauge haemorrhage progression risk in patients suffering severe traumatic brain injury and to explore the related rates of VTE. Of their study group; 158 patients were treated with LMWH, 171 were treated with UFH and 57 patients had sequential compression devices, the latter considered the control group. The observed incidence of VTE within the treated groups of patients was 0.9% and 1.9% respectively. Patients in the untreated group had a 47% mortality rate in stark contrast to the observed 5% in the LMWH group and 16% in the UFH group. In patients treated with UFH the incidence of DVT was 1% and 3.7% for PE, only marginally higher than those patients treated with LMWH. After the commencement of treatment, only 8 (5%) patients in the LMWH group and 20 patients (12%) in the UFH group had a progression of their in-tracranial haemorrhage which, as with the study by Farooqui et al., (2013) , is considerably lower than their control group with a progression rate of 25%. Again, early initiation of anticoagulant prophylaxis in patients with severe TBI was shown to significantly reduce the risk of VTE without significant risk of intracranial haemorrhage progression. Depew, Hu, Nguyen & Driessen (2008) , suggested early prophylaxis had merit following conducting a retrospective study including 124 patients who suffered blunt head trauma reviewed rates of ICH progression with early prophylaxis. 62 patients were commenced on LMWH, 20 patients on UFH and 42 patients had pneumatic compression devices alone. Of those with chemical VTE prophylaxis, 10 developed VTE and 3 developed ICH progression of which only one was significant. In contrast, a decision analysis study conducted by Niemi & Armstrong (2010) proposed that if bleeding risk was high intraoperatively, the administration of anticoagulant prophylaxis should be postponed until as late as possible, but consequences should be considered case dependent. They concluded that patients considered very high risk from thrombus development should have anticoagulant prophylaxis implemented provided risk of inadequate prevention outweighed the risk of bleeding.
Nursing Considerations
The essential role of the neuroscience nurse is continually evolving. Neuroscience nurses are conscientiously accountable for the coordination of patient care throughout recovery and are instrumental in the prevention of VTE in the neurosurgical setting. Prevention of VTE and risk reduction should be considered fundamental nursing goals (Andrews & Habashi, 2010) . Rapid patient assessment in order to review effectiveness of care, quick identification of issues and prompt management of complications is essential in high risk patients. Due to their close affiliation to the patient, the nurse is often the first to observe the clinical signs associated with VTE and is responsible for implementing prevention strategies and treatment for those who develop DVT or PE. DVT, as described in Scruth & Haynes (2014) , typically presents with pain in the calf, often with redness, swelling and distended superficial veins. The affected calf is often warmer to touch and Homan's sign, pain in the calf on dorsiflexion of the foot, may also be present. Although a late sign of DVT, cyanotic discolouration due to deoxygenated haemoglobin present within the stagnant veins, may also be present (Söhne, Vink & Büller, 2009) . As explained in Hix & Tamburri (2009) , the signs and symptoms of PE include dyspnoea, tachypnoea, inspirational chest pain, chest wall tenderness, decreased spO2, cough, cyanosis, tachycardia, fever and haemoptysis. PE may present with varied signs and this can often make the diagnosis challenging (Mathers, 2015) . A possible PE should be considered in any patient who displays or reports new onset of cardiorespiratory signs and symptoms or any risk factors for VTE (Hix & Tamburri, 2009 ).
The neuroscience nurse is also responsible for providing sufficient patient education for patients considered high risk or who have developed DVT or PE. In the context of ICU patients, Andrews & Habashi (2010) , recommend the use of minimal sedation where possible to promote activity including ventilator management and weaning as early as possible and the implementation and continuation of prophylaxis for the prevention of VTE. It is extremely important that the neuroscience nurse be attuned to the potential for patients to precipitously deteriorate in the setting of anticoagulant prophylaxis, particularly given the inability to immediately reverse the effects of anticoagulants such as, LMWH, given that an exclusive antidote is not available (Niemi & Armstrong, 2010) .
Conclusion
VTE thromboprophylaxis in the neurosurgical setting remains controversial and can be challenging and complex. As highlighted in the review, the consequences of VTE can be devastating and patients with neurotrauma are amongst those at greatest risk. Complicating that which would otherwise be a simple matter, the risk of haemorrhagic progression and the consequences of postoperative bleeding lend credence to a more conservative approach, with delays to onset of chemical prophylaxis being the most commonly described intervention. As a nurse within the neurosurgical field, the key challenges remain early detection of VTE complications within the untreated cohort of patients, and the early detection of haemorrhage within the treated population.
